Letter to the Editor
Authors’ reply: Human papillomavirus vaccine and primary ovarian failure
Serena Colafrancesco,
Serena Colafrancesco
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy
Search for more papers by this author Carlo Perricone,
Carlo Perricone
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy
Search for more papers by this author Lucija Tomljenovic,
Lucija Tomljenovic
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Neural Dynamics Research Group, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this author Yehuda Shoenfeld,
Yehuda Shoenfeld
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author
Serena Colafrancesco,
Serena Colafrancesco
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy
Search for more papers by this author Carlo Perricone,
Carlo Perricone
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy
Search for more papers by this author Lucija Tomljenovic,
Lucija Tomljenovic
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Neural Dynamics Research Group, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this author Yehuda Shoenfeld,
Yehuda Shoenfeld
Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author
First published: 10 January 2014
Correspondence
Yehuda Shoenfeld, Department of Medicine, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.
E-mail: [email protected]
No abstract is available for this article.
References
- 1Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y: HPV vaccines and primary ovarian failure: another facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA). Am J Reprod Immunol 2013; 70: 309–316.
- 2Little DT, Ward HR: Premature ovarian failure 3 years after menarche in a 16-year old girl following human papillomavirus vaccination. BMJ Case Rep 2012. [epub ahead of print]. doi: 10.1136/bcr-2012-006879.
- 3 Merck. Gardasil product sheet, Date of Approval 2006. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM111263.pdf
- 4Gatto M, Agmon-Levin N, Soriano A, Manna R, Maoz-Segal R, Kivity S, Doria A, Shoenfeld Y: Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol 2013; 32: 1301–1307.
- 5Harper DM, Nieminen P, Paavonen J, Lehtinen M: Cervical cancer incidence can increase despite HPV vaccination. Lancet Infect Dis 2010; 10: 594–595; author reply 595.
- 6Tomljenovic L, Spinosa JP, Shaw CA: Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (How) effective and safe? Curr Pharm Des 2013; 19: 1466–1487.
